Ken Griffin
APYX icon

Ken Griffin’s Apyx Medical APYX Stock Holding History

Ken Griffin’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$398K Buy
+107,798
New +$403K ﹤0.01% 9825
2025
Q4 		– Sell
-13,292
Closed -$28.4K – 12594
2025
Q3 		$28.4K Buy
+13,292
New +$28.1K ﹤0.01% 12414
2025
Q2 		– Sell
-13,566
Closed -$18.6K – 12426
2025
Q1 		$18.6K Sell
13,566
-52,789
-80% -$72.7K ﹤0.01% 13196
2024
Q4 		$105K Buy
66,355
+53,782
+428% +$75.2K ﹤0.01% 11421
2024
Q3 		$15.6K Buy
12,573
+9,297
+284% +$11.7K ﹤0.01% 12963
2024
Q2 		$4.39K Buy
+3,276
New +$4.83K ﹤0.01% 13490
2024
Q1 		– Sell
-59,785
Closed -$127K – 14509
2023
Q4 		$157K Buy
59,785
+45,329
+314% +$110K ﹤0.01% 10319
2023
Q3 		$46.3K Buy
14,456
+11,791
+442% +$54.9K ﹤0.01% 11839
2023
Q2 		$13.4K Sell
2,665
-111,168
-98% -$563K ﹤0.01% 13043
2023
Q1 		$328K Buy
113,833
+38,578
+51% +$113K ﹤0.01% 9199
2022
Q4 		$176K Buy
75,255
+59,279
+371% +$181K ﹤0.01% 10358
2022
Q3 		$72K Sell
15,976
-79,156
-83% -$567K ﹤0.01% 11352
2022
Q2 		$557K Buy
+95,132
New +$488K ﹤0.01% 8410
2022
Q1 		– Sell
-32,044
Closed -$411K – 13515
2021
Q4 		$411K Sell
32,044
-17,722
-36% -$248K ﹤0.01% 10144
2021
Q3 		$689K Sell
49,766
-13,138
-21% -$138K ﹤0.01% 9111
2021
Q2 		$649K Buy
62,904
+42,071
+202% +$417K ﹤0.01% 9420
2021
Q1 		$202K Buy
+20,833
New +$208K ﹤0.01% 11680
2020
Q2 		– Sell
-20,875
Closed -$75K – 9727
2020
Q1 		$75K Buy
+20,875
New +$140K ﹤0.01% 8818
2019
Q2 		– Sell
-18,201
Closed -$115K – 9125
2019
Q1 		$115K Sell
18,201
-23,233
-56% -$180K ﹤0.01% 8493
2018
Q4 		$268K Buy
41,434
+26,661
+180% +$161K ﹤0.01% 7446
2018
Q3 		$105K Buy
+14,773
New +$82.1K ﹤0.01% 8553
2017
Q3 		– Sell
-11,957
Closed -$30K – 7495
2017
Q2 		$30K Buy
+11,957
New +$29.4K ﹤0.01% 7200
2017
Q1 		– Sell
-11,951
Closed -$43K – 7399
2016
Q4 		$43K Buy
+11,951
New +$53.2K ﹤0.01% 6897
2016
Q2 		– Sell
-10,964
Closed -$18K – 6788
2016
Q1 		$18K Buy
+10,964
New +$22.1K ﹤0.01% 6490

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Ken Griffin's APYX Position: Q1 2026 in Review

Ken Griffin opened a new position in Apyx Medical (APYX) in Q1 2026: 107,798 shares worth $398K. The stake represents ﹤0.01% of the portfolio and ranks #9825 among its holdings. This is a return to the name: Ken Griffin previously reported a position in APYX as recently as Q3 2025.

Ken Griffin first reported a position in APYX in Q1 2016 and has held it in 24 quarters since. The position peaked at $689K in Q3 2021. 67 funds tracked by Wall St. Rank hold APYX as of Q1 2026.

  • Ken Griffin held 107,798 shares of Apyx Medical worth $398K as of Q1 2026.
  • Apyx Medical was a new Ken Griffin position in Q1 2026.
  • Apyx Medical made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #9825 holding.
  • Ken Griffin first reported a position in Apyx Medical in Q1 2016 and has held it in 24 quarters since.
  • Ken Griffin's Apyx Medical position peaked at $689K in Q3 2021.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.